Literature DB >> 11136498

Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy.

P Giannuzzi1, P L Temporelli, E Bosimini, F Gentile, D Lucci, A P Maggioni, L Tavazzi, L Badano, I Stoian, R Piazza, I Heyman, G Levantesi, E Cervesato, E Geraci, G L Nicolosi.   

Abstract

BACKGROUND: Left ventricular (LV) remodeling after acute myocardial infarction has still to be clarified in the thrombolytic era.
METHODS: To evaluate timing and the magnitude and pattern of postinfarct LV remodeling, a subset of 614 patients enrolled in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy underwent serial 2-dimensional echocardiograms at 24 to 48 hours from symptom onset (S1), at hospital discharge (S2), at 6 weeks (S3), and at 6 months (S4) after acute myocardial infarction.
RESULTS: During the study period the end-diastolic volume index (EDVi) increased (P <.001) and wall motion abnormalities (%WMA) decreased (P <.001), whereas ejection fraction (EF) remained unchanged. Nineteen percent of patients showed a > 20% increase in EDVi at S2 compared with S1 (severe early dilation), and 16% of patients showed a > 20% dilation at S4 compared with S2 (severe late dilation). Independent predictors of severe in-hospital LV dilation were relatively small EDVi (odds ratio [OR] 0.961, 95% confidence interval [CI] 0.947-0.974, P =.0001) and relatively large %WMA (OR 1.030, 95% CI 1.013-1.048, P =.0005). Similarly, smaller predischarge EDVi (OR 0.975, 95% CI 0. 963-0.987, P =.0001), greater %WMA (OR 1.026, 95% CI 1.008-1.045, P =.0042), and moderate to severe mitral regurgitation (OR 2.261, 95% CI 1.031-4.958, P = 0.0417) independently predicted severe late dilation. Importantly, 92% of the patients with severe early dilation did not have further dilation at S4, and 91% of patients with severe late dilation did not have in-hospital dilation. EF was unchanged over time in patients with early dilation, whereas it significantly decreased in those with late dilation.
CONCLUSIONS: Although in-hospital LV enlargement is not predictive of subsequent dilation and dysfunction, late remodeling is associated with progressive deterioration of global ventricular function over time: patients with extensive %WMA and not significantly enlarged ventricular volume before discharge are at higher risk for progressive dilation and dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11136498     DOI: 10.1067/mhj.2001.111260

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  25 in total

1.  Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders.

Authors:  Donato Mele; Roberta Teoli; Corrado Cittanti; Giovanni Pasanisi; Gabriele Guardigli; Robert A Levine; Roberto Ferrari
Journal:  Int J Cardiovasc Imaging       Date:  2004-06       Impact factor: 2.357

2.  Influence of contractile reserve and inducible ischaemia on left ventricular remodelling after acute myocardial infarction.

Authors:  C Coletta; A Sestili; F Seccareccia; R Rambaldi; R Ricci; A Galati; R Bigi; N Aspromonte; M Renzi; V Ceci
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

3.  Heart failure with recovered ejection fraction.

Authors:  Kazuaki Tanabe; Takahiro Sakamoto
Journal:  J Echocardiogr       Date:  2018-09-14

4.  beta-Adrenergic receptor blockers and heart failure risk after myocardial infarction: a critical review.

Authors:  Robert H Neumayr; Paul J Hauptman
Journal:  Curr Heart Fail Rep       Date:  2009-12

5.  Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction.

Authors:  L De Luca; G Sardella; C J Davidson; G De Persio; M Beraldi; T Tommasone; M Mancone; B L Nguyen; L Agati; M Gheorghiade; F Fedele
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

6.  Right ventricular functional recovery after acute myocardial infarction: relation with left ventricular function and interventricular septum motion. GISSI-3 echo substudy.

Authors:  B A Popescu; F Antonini-Canterin; P L Temporelli; P Giannuzzi; E Bosimini; F Gentile; A P Maggioni; L Tavazzi; R Piazza; L Ascione; I Stoian; E Cervesato; A C Popescu; G L Nicolosi
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

7.  Post-myocardial infarction intraventricular conduction defects and B-type natriuretic peptide levels.

Authors:  Katarzyna Ciuraszkiewicz; Marianna Janion; Janusz Sielski; Dariusz Dudek; Zenon Gawor
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

8.  Left Ventricular Dyssynchrony After Acute Myocardial Infarction is a Powerful Indicator of Left Ventricular Remodeling.

Authors:  Jum Suk Ko; Myung Ho Jeong; Min Goo Lee; Shin Eun Lee; Won Yu Kang; Soo Hyun Kim; Keun-Ho Park; Doo Sun Sim; Nam Sik Yoon; Hyun Ju Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2009-06-30       Impact factor: 3.243

9.  Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.

Authors:  C Siva Sankara; D Rajasekhar; V Vanajakshamma; B S Praveen Kumar; A Vamsidhar
Journal:  Indian Heart J       Date:  2015-05-20

10.  Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study.

Authors:  Stefania Funaro; Giuseppe La Torre; Mariapina Madonna; Leonarda Galiuto; Antonio Scarà; Alessandra Labbadia; Emanuele Canali; Antonella Mattatelli; Francesco Fedele; Francesco Alessandrini; Filippo Crea; Luciano Agati
Journal:  Eur Heart J       Date:  2008-12-18       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.